Skip to main content
Clinical Trials/NCT05966935
NCT05966935CompletedNot Applicable

Effect of Fenugreek and Cumin Powder on Anthropometric Indices of Overweight and Obese Adults

University of Veterinary and Animal Sciences, Lahore - Pakistan1 site in 1 country60 target enrollmentStarted: September 15, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Change in Waist- Hip Ratio

Study Overview

Brief Summary

The objective of this study is to investigate the effect of fenugreek and cumin powder on the anthropometric indices of overweight and obese adults aged 18-30 years. This study design intends to answer following question:

Will fenugreek and cumin powder mixture result in change of anthropometric measurements {Body Mass Index[BMI], Waist-Hip Ratio, Fat Mass

Detailed Description

Obesity is a chronic disorder of carbohydrate and lipid metabolism and is characterized by an increased fat deposition in adipose tissue and other internal organs .

Obesity leads to the development of insulin resistance, type-2 diabetes, coronary heart disease, cancer, respiratory disease, and osteoarthritis. The World Obesity Atlas 2022 predicts that one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030.

Pakistan ranks tenth out of 188 countries, with 50% of population overweight or obese Several studies have investigated the effect of fenugreek and cumin supplementation on anthropometric measures but the findings have been inconsistent. Only few studies directly focused on powder supplementation. The study aims to investigate the effect of fenugreek and cumin powder supplementation on body measurements for weight loss. This will help in developing a rather inexpensive, herbal mixture for weight loss.

Galactomannan present in fenugreek capture and excrete sugars from body before it moves in the blood, this causes the loss of weight The percent gain in body weight was significantly low in groups supplemented with fenugreek Cumin improves anthropometric indices in overweight. Cumin powder reduced weight, Body Mass Index[BMI], waist circumference, fat mass and percentage significantly.

This study consists of following phases Phase 1: Fenugreek and cumin powder preparation Phase 2: 30 Participants will be recruited after filling the consent form and screened through a questionnaire throughout the university. Individuals with Body Mass Index[BMI] >23kg/m2, Waist-Hip-Ratio >0.8 will be recruited in the study after fulfilling the criterion (patients of thyroid, Polycystic ovary syndrome[PCOS], Hypertension[HTN] will be excluded). Participants not following any fitness regime or specific diet will be recruited further. Baseline body measurements will be taken by inbody analyzer. They will be given powder packed in packets to be used for 8 weeks twice a day before breakfast and dinner. Experimental Design : Overweight and obese adults will be assigned to two groups ( Intervention group and control). Participants will be requested to record the following information daily: Consumption of FCP( fenugreek cumin powder) and any side effects if experienced after consumption.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •overweight and obese( BMI>23 kg/m^2)

Exclusion Criteria

  • •pregnant women
  • •fitness regime
  • •specific diet

Arms & Interventions

fenugreek cumin powder

Experimental

Overweight and Obese adults in this group will receive fenugreek cumin powder daily twice a day before morning and evening meals for 8 weeks

Intervention: Fenugreek Cumin Powder (Combination Product)

Control group

No Intervention

Overweight and obese participants in this group will not receive fenugreek and cumin powder or any intervention for 8 weeks

Outcomes

Primary Outcomes

Change in Waist- Hip Ratio

Time Frame: change from baseline reading after 2 months

the WHR will be calculated using inbody analyzer 270

weight change in kilograms

Time Frame: change from baseline weight after 2 months

Electronic weighing scale will be used to assess weight change in both groups

Change in Body fat mass in kilograms and percentages

Time Frame: change from baseline readings after 2 months

body fat mass and percentage will be assessed through inbody analyzer 270

Change in BMI in kg/m^2

Time Frame: change from baseline reading after 2 months

the BMI will be calculated using weight(kg) and height(m\^2)

Secondary Outcomes

  • Change in Basal metabolic Rate( BMR)(Change from baseline after 2 months)
  • change in Protein mass of body (grams)(change from baseline reading after 2 months)

Investigators

Sponsor
University of Veterinary and Animal Sciences, Lahore - Pakistan
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sanaullah Iqbal

Professor

University of Veterinary and Animal Sciences, Lahore - Pakistan

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Effect of fenugreek seed on the treatment of diabeteson-insulin-dependent diabetes mellitus.Type 2 diabetes mellitus
IRCT20190618043924N1Kerman University of Medical Sciences50
Completed
Not Applicable
Effect of Fenugreek on the Treatment of DiabetesNon-insulin-dependent diabetes mellituson-insulin-dependent diabetes mellitus.
IRCT2017072732294N3Vice chancellor for research, Isfahan University of Medical Sciences48
Completed
Not Applicable
The effect of fenugreek seeds on some gastrointestinal disorder in patients with mechanical ventilation.Condition 1: Cerebrovascular diseases. Condition 2: Chronic lower respiratory diseases. Condition 3: Hypertensive diseases. Condition 4: Diseases of the nervous system. Condition 5: Ischaemic heart diseases. Condition 6: Diseases of the circulatory system. Condition 7: Diabetes Mellitus.Cerebral infarction, Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction , Other cerebrovascular diseasesChronic lower respiratory diseasesEssential (primary) hypertension , Hypertensive heart disease ,Secondary hypertensionDemyelinating diseases of the central nervous systemChronic ischaemic heart disease, Chronic ischaemic heart disease,I63, I65,J40, J41,I10, I11,I23. I25163, 166E10-E14Diabetes MellitusCerebral infarction
IRCT2016021126511N1Sabzevar University of Medical Sciences
Not yet recruiting
Phase 3
Effect of Cumin Powder on Obesity
CTRI/2020/03/024157Suganya
Recruiting
Not Applicable
curcumin supplementation in overweight/obese female studentsoverweight and obesity.
IRCT20171107037302N1Esfahan University of Medical Sciences60